Skip to content
10-K

Annual Report

CELLULAR BIOMEDICINE GROUP, INC.

0001654954-20-002065

← back to feed
Filed
Feb 28, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Feb 24, 2020 19.36M sh
Shares Diluted FY 2019 · Dec 31, 2019 18.98M sh
Shares Diluted FY 2019 · Dec 31, 2018 17.74M sh
Shares Diluted FY 2019 · Dec 31, 2017 14.35M sh
Operating Cash Flow FY 2019 · Dec 31, 2019 −$39.65M
Operating Cash Flow FY 2019 · Dec 31, 2018 −$25.11M
Operating Cash Flow FY 2019 · Dec 31, 2017 −$18.59M
Short Term Debt FY 2019 · Dec 31, 2019 $14.33M
Short Term Debt FY 2019 · Dec 31, 2018 $0
Cash And Equivalents FY 2019 · Dec 31, 2019 $15.44M
Cash And Equivalents FY 2019 · Dec 31, 2018 $52.81M
Stockholders Equity FY 2019 · Dec 31, 2019 $55.72M
Stockholders Equity FY 2019 · Dec 31, 2018 $85.22M
Stockholders Equity FY 2019 · Dec 31, 2017 $57.3M
Stockholders Equity FY 2019 · Dec 31, 2016 $65.89M
Current Liabilities FY 2019 · Dec 31, 2019 $23.67M
Current Liabilities restated FY 2019 · Dec 31, 2018 $8.04M
Total Liabilities FY 2019 · Dec 31, 2019 $41.61M
Total Liabilities restated FY 2019 · Dec 31, 2018 $22.36M
Current Assets FY 2019 · Dec 31, 2019 $34.03M
Current Assets FY 2019 · Dec 31, 2018 $54.61M
Total Assets FY 2019 · Dec 31, 2019 $97.32M
Total Assets restated FY 2019 · Dec 31, 2018 $107.58M
Sga Expense FY 2019 · Dec 31, 2019 $13.46M
Sga Expense FY 2019 · Dec 31, 2018 $13.22M
Sga Expense FY 2019 · Dec 31, 2017 $12.78M
Rd Expense FY 2019 · Dec 31, 2019 $37.67M
Rd Expense FY 2019 · Dec 31, 2018 $24.15M
Rd Expense FY 2019 · Dec 31, 2017 $14.61M
Net Income FY 2019 · Dec 31, 2019 −$12.69M
Net Income FY 2019 · Dec 31, 2019 −$49.98M
Net Income FY 2019 · Sep 30, 2019 −$15.86M
Net Income FY 2019 · Jun 30, 2019 −$12.1M
Net Income FY 2019 · Mar 31, 2019 −$9.34M
Net Income FY 2019 · Dec 31, 2018 −$8.52M
Net Income FY 2019 · Dec 31, 2018 −$38.95M
Net Income FY 2019 · Sep 30, 2018 −$12.74M
Net Income FY 2019 · Jun 30, 2018 −$9.19M
Net Income FY 2019 · Mar 31, 2018 −$8.5M
Net Income FY 2019 · Dec 31, 2017 −$25.49M
Operating Income FY 2019 · Dec 31, 2019 −$12.8M
Operating Income FY 2019 · Dec 31, 2019 −$50.99M
Operating Income FY 2019 · Sep 30, 2019 −$16.49M
Operating Income FY 2019 · Jun 30, 2019 −$12.28M
Operating Income FY 2019 · Mar 31, 2019 −$9.42M
Operating Income FY 2019 · Dec 31, 2018 −$9.81M
Operating Income FY 2019 · Dec 31, 2018 −$40.51M
Operating Income FY 2019 · Sep 30, 2018 −$12.8M
Operating Income FY 2019 · Jun 30, 2018 −$9.39M
Operating Income FY 2019 · Mar 31, 2018 −$8.51M
Operating Income FY 2019 · Dec 31, 2017 −$27.58M
Gross Profit FY 2019 · Dec 31, 2019 $236.36K
Gross Profit FY 2019 · Dec 31, 2019 $277.54K
Gross Profit FY 2019 · Sep 30, 2019 $0
Gross Profit FY 2019 · Jun 30, 2019 $0
Gross Profit FY 2019 · Mar 31, 2019 $41.18K
Gross Profit FY 2019 · Dec 31, 2018 $4.11K
Gross Profit FY 2019 · Dec 31, 2018 $88.64K
Gross Profit FY 2019 · Sep 30, 2018 $32.95K
Gross Profit FY 2019 · Jun 30, 2018 $22.92K
Gross Profit FY 2019 · Mar 31, 2018 $28.66K
Cost Of Revenue FY 2019 · Dec 31, 2019 $62.38K
Cost Of Revenue FY 2019 · Dec 31, 2018 $135.76K
Cost Of Revenue FY 2019 · Dec 31, 2017 $162.22K
Revenue FY 2019 · Dec 31, 2019 $290.66K
Revenue FY 2019 · Dec 31, 2019 $339.92K
Revenue FY 2019 · Sep 30, 2019 $0
Revenue FY 2019 · Jun 30, 2019 $0
Revenue FY 2019 · Mar 31, 2019 $49.27K
Revenue FY 2019 · Dec 31, 2018 $25.7K
Revenue FY 2019 · Dec 31, 2018 $224.4K
Revenue FY 2019 · Sep 30, 2018 $70.43K
Revenue FY 2019 · Jun 30, 2018 $77.31K
Revenue FY 2019 · Mar 31, 2018 $50.96K
Revenue FY 2019 · Dec 31, 2017 $336.82K